INCR InterCure: רווח נקי למניה ב-12 החודשים האחרונים

InterCure Ltd. (INCR) is an international player in the medical cannabis market that relies on pharmacy control and digital prescriptions in Israel while expanding its presence in Europe. The EPS (TTM) price action reflects a current figure of 0.00. However, the business remains vulnerable to geopolitical shocks and strict regulatory oversight, which, combined with raw material price volatility, poses significant threats to operating profitability.
Canndoc - פילוחים אנליטיים ומדדי מפתח (INCR)

EPS (TTM) growth measures the annual change in net income per share over a rolling period, allowing for an assessment of return on equity dynamics excluding the control premium. By analyzing this rolling year YoY EPS growth chart, an investor can see the impact of medical cannabis regulatory risks in Israel and Europe on the actual ability of InterCure Ltd. (INCR) to generate profit.